DC magnetic field induced magnetocytolysis of cancer cells targeted by LH-RH magnetic nanoparticles in vitro

Biomedical Microdevices

Volumn 4, Issue 4, 2002, Pages 293-299

  Bergey, Earl J ^a   Levy, Laurent ^a   Wang, Xiaopeng ^a   Krebs, Linda J ^a   Lal, Manjari ^a   Kim, Kyoung Soo ^a   Pakatchi, Shadi ^a   Liebow, Charles ^a   Prasad, Paras N ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC OXIDE; FLUORESCENT DYE; GONADORELIN; GONADORELIN RECEPTOR; NANOPARTICLE; PEPTIDE DERIVATIVE;

ARTICLE; CANCER CELL; CANCER THERAPY; CELL TYPE; CHEMICAL LABELING; CONTROLLED STUDY; CYTOLYSIS; DIRECT CURRENT; EXPOSURE; HUMAN; HUMAN CELL; IMAGING; IN VITRO STUDY; MAGNETIC FIELD; MAGNETISM; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICS; PRIORITY JOURNAL;

EID: 0036917032     PISSN: 13872176     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020906307053     Document Type: Article

References (23)

1. D.S. Alberts, J. Clin. Oncol. 17, 13 (1999).
2. J. Aucouturier, L. Dupuis, and V. Ganne, Vaccine 19, 2666 (2001).
3. H.A. Clark, R. Kopelman, R. Tjalkens, and M.A. Philbert, Anal. Chem. 71, 4837 (1999).
4. H.A. Clark, M. Hoyer, M.A. Philbert, and R. Kopelman, Anal. Chem. 71, 4831 (1999a).
5. D.H. Crean, C. Liebow, M.T Lee, A.R. Kamer, and T.S. Mang, Cancer Res. Clinical Oncol. 121, 141 (1995).
6. E. Emons, B. Schroder, O. Ortmann, S. Westphalen, D.D. Schulz, and A.V. Schally, J. Clin. Endocrinol. Metab. 77, 1458 (1993).
7. N. Feltin and M.P. Pileni, Langmuir 13, 3927 (1997).
8. A. Halbreich, J. Rodger, J.N. Pons, D. Geldwerth, M.F. Da Silva, M. Roudier, and J.C. Bacri, Biochimie 80, 379 (1998).
9. G.S. He, L. Yuan, Y. Cui, M. Li, and P.N. Prasad, J. Appl. Phys. 81, 2529 (1997).
10. I. Higler, W. Andra, R. Bahring, A. Daum, R. Hergt, and W.A. Kaiser, Invest. Rad. 32, 705 (1997).
11. D. Hogemann, L. Josephson, R. Weissleder, and J.P. Basilion, Bioconjugate Chem. 11, 941 (2000).
12. J. Kreuter, J. Anat. 189, 503 (1996).
13. J. Kreuter, Pharma. Biotech. 6, 463 (1995).
14. C. Liebow, M.T Lee, A.R. Kamer, and A.V. Schally, Proc. Natl. Acad. Sci. USA 88, 2244 (1991).
15. A. Nagy, A.V. Schally, P. Armatis, K. Szepeshazi, G. Halmos, M. Kovacs, M. Zarandi, K. Groot, M. Miyazaki, A. Jungwirth, and J. Horvath, Proc. Natl. Acad. Sci. USA, 93, 7269 (1996).
16. M. Qhobosheane, S. Santra, P. Zhang, and W. Tan, Analyst 12, 1274 (2001).
17. B.R. Rosen and T.J. Brady, J. Comp. Assist. Tomog. 17, S36 (1993).
18. A. V. Schally and A. Nagy, Eur. I Endocrinology 141, 1 (1999).
19. W. Schutt, C. Gruttner, U. Hafeli, M. Zborowski, J. Teller, H. Putzar, and C. Schumichen, Hybridoma 16, 109 (1997).
20. A.G. Tibbe, B.G. de Grooth, J. Greve, PA. Liberti, G.J. Dolan, and L.W. Terstappen, Nature Biotech. 17, 1210 (1999).
21. I. Tohnai, Y. Goto, Y. Havashi, M. Ueda, Y. Kobayashi, and M. Matsui, Int. J. of Hypertherm. 12, 37 (1996).
22. M. Yanase, M. Shinkai, H. Honds, T. Wakabayashi, J. Yoshida, and T. Kobayashi, Jpn. J. Cancer Res. 89, 775 (1998).
23. X. Wang, L.J. Krebs, M. Al-Nuri, H.E. Pudavar, S. Ghosal, C. Liebow, A. Nagy, AX Schally, and P.N. Prasad, Proc. Natl. Acad. Sci. USA 96, 11081 (1999).